The Effective Statistician - in association with PSI Podcast Por Alexander Schacht and Benjamin Piske biometricians statisticians and leaders in the pharma industry arte de portada

The Effective Statistician - in association with PSI

The Effective Statistician - in association with PSI

De: Alexander Schacht and Benjamin Piske biometricians statisticians and leaders in the pharma industry
Escúchala gratis

Acerca de esta escucha

The podcast from statisticians for statisticians to have a bigger impact at work. This podcast is set up in association with PSI - Promoting Statistical Insight. This podcast helps you to grow your leadership skills, learn about ongoing discussions in the scientific community, build you knowledge about the health sector and be more efficient at work. This podcast helps statisticians at all levels with and without management experience. It is targeted towards the health, but lots of topics will be important for the wider data scientists community.Alexander Schacht Ciencia Historia Natural Naturaleza y Ecología
Episodios
  • Inclusion for All: Rethinking Success, Neurodiversity, and Accessibility in the Workplace
    37 m
  • Daily updated systematic literature reviews - the future of oncology
    May 19 2025
    How can oncologists and healthcare professionals keep up with the ever-growing body of research to make the best decisions for patients? In this episode, I speak with Anna Forsythe, a pharmacologist, health economist, and founder of OncoScope, a groundbreaking platform delivering daily updated systematic literature reviews (SLRs) in oncology. Drawing on decades of experience in pharma and health economics, Anna shares how automation and AI are transforming the traditionally tedious SLR process—making up-to-date evidence accessible to clinicians in just a few clicks. Anna’s vision is clear: democratize access to high-quality, current evidence for clinicians—and ultimately improve patient care.
    Más Menos
    23 m
  • A novel approach for finding predictive biomarkers
    May 12 2025
    In this episode, I’m joined by Julia Geronimi from Servier and Dr. Pavel Mozgunov from the University of Cambridge to explore a topic that’s absolutely central to advancing precision medicine—predictive biomarkers. We dive into the challenges of identifying predictive vs. prognostic biomarkers, especially in early-phase clinical trials with limited sample sizes. What makes their approach so exciting is that it offers a model-flexible, visually intuitive way to detect predictiveness—even before we talk about dichotomizing biomarkers or setting cutoffs. If you work on clinical trial design, translational science, or biomarker development, this conversation will give you fresh tools—and a lot to think about.
    Más Menos
    36 m
adbl_web_global_use_to_activate_T1_webcro805_stickypopup
Todavía no hay opiniones